1. Peri‐marketing surveillance of lamotrigine in the Netherlands: Doctors' and patients' viewpoints

   • D.G.A. Kasteleijn‐Nolst Trenité
   • K.G.P.M. Gilissen
   • A. Schlosser

   Legacy Pages: 1 - 5

2. The perceived role and skills of pharmacists in asthma management after in‐house training

   • Kirsti K. Vainio
   • Maarit J.H. Korhonen
   • Anne M. Hirvonen

   Legacy Pages: 6 - 12

3. The role of the community pharmacist in drug abuse: a comparison of service provision between Northern Ireland and England/Wales

   • Glenda F. Fleming
   • James C. McElnay
   • John Strang

   Legacy Pages: 13 - 16

4. Pharmacotherapeutical options in inflammatory bowel disease: an update

   • Y.H. Kho
   • M. Oudkerk Pool
   • J.W. Harting

   Legacy Pages: 17 - 21

5. "No thank you": Why elderly patients declined to participate in a research study

   • D.R. Petty
   • A.G. Zermansky
   • N. Freemantle

   Legacy Pages: 22 - 27

6. Comparative trials in registration files of cardiovascular drugs: Comparator drugs and dosing schemes.

   • N.F. Wieringa
   • R. Vos
   • P.A. de Graeff

   Legacy Pages: 28 - 30

7. Pharmacist involvement with warfarin dosing for inpatients

   • Chris Boddy

   Legacy Pages: 31 - 35

8. Neuropsychiatric symptoms during cefepime treatment

   • Willem Diemont
   • Marius MacKenzie
   • Kees van Grootheest

   Legacy Pages: 36 - 36

9. Letter

   Announcement Pages: 37 - 37

10. ESCP Conference 2001, Malta – The nd Spring Conference on Clinical Pharmacy under the title:

    Announcement Pages: 38 - 38

11. Acknowledgement of external reviewers

    Announcement Pages: 39 - 39

12. Announcement – 9th International Cochrane Colloquium 2001

    Announcement Pages: 40 - 40